Tamoxifen 50Tab 10Mg Tamoxifen 2

Description

Overview

Blocks estrogen at breast tissue (helps gyno) and at the hypothalamus (raises LH/FSH); used for gyno management and PCT.

Composition / Profile

• Active compound: Tamoxifen
• Drug class: Selective estrogen receptor modulator (SERM)
• Pack / dose (this listing): 50tab / 10mg

Format

• Oral tablet
• Pack / dose: 50tab / 10mg

Dosage & Usage Patterns

• Bodybuilding (commonly cited): Commonly cited PCT: ~40 mg/day for 2 weeks then 20 mg/day for 2–4 weeks; also used for gynecomastia at ~20–40 mg/day.
• Clinical / general reference: Individual; used in structured recovery/anti-gyno protocols.
• Half-life: ~5-7 days.
• Protocols vary by individual, compound stack, and bloodwork — figures above reflect community-reported patterns, not medical recommendations.

Effects

Reported benefits (commonly cited)

• Blocks estrogen at breast tissue (anti-gyno).
• Stimulates HPTA via hypothalamic estrogen receptor blockade.
• Core PCT agent.

Reported side effects

• Mood changes, nausea, small VTE (clotting) risk, vision changes (rare).

Key Interactions

• Interacts with some antidepressants (CYP2D6) and anticoagulants.
• Estrogen-receptor activity.

Role in Post-Cycle Therapy

• Core PCT agent and gyno treatment.
• Raises endogenous gonadotropins.

Precautions

• Clotting risk relevant in predisposed individuals.
• Combine-with-AI logic should be clinician-guided.

Common Misconception

Myth: ‘Nolva blocks all estrogen everywhere.’
Evidence: it’s a modulator — antagonist in some tissues, agonist in others (e.g., bone/liver).

Related Categories

• Browse more in Post Cycle Therapy (PCT) → Tamoxifen.

Storage

• Store in a cool, dry place away from direct light and moisture